EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment

Jannik Paulus, Norbert Sewald iD

Journal of Peptide Science · 2024-07 · 30 (7)

DOI: 10.1002/psc.3561 ↗

At a glance

Übersichtsarbeit in Journal of Peptide Science, published online on 2024-02-21. Written by Jannik Paulus and 1 co-authors. Institution: Organic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, Bielefeld, Germany. Major MEDLINE topics: Neoplasms, Peptides, Antineoplastic Agents, Integrins. Cited 23 times so far (Crossref); 457 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Targeted cancer treatment should avoid side effects and damage to healthy cells commonly encountered during traditional chemotherapy. By combining small molecule or peptidic ligands as homing devices with cytotoxic drugs connected by a cleavable or non‐cleavable linker in peptide–drug conjugates (PDCs) or small molecule–drug conjugates (SMDCs), cancer cells and tumours can be selectively targeted. The development of highly affine, selective peptides and small molecules in recent years has allowed PDCs and SMDCs to increasingly compete with antibody‐drug conjugates (ADCs). Integrins represent an excellent target for conjugates because they are overexpressed by most cancer cells and because of the broad knowledge about native binding partners as well as the multitude of small‐molecule and peptidic ligands that have been developed over the last 30 years. In particular, integrin α V β 3 has been addressed using a variety of different PDCs and SMDCs over the last two decades, following various strategies. This review summarises and describes integrin‐addressing PDCs and SMDCs while highlighting points of great interest.

Subjects

MeSH terms (MEDLINE)

NeoplasmsPeptidesAntineoplastic AgentsIntegrinsHumansImmunoconjugatesSmall Molecule LibrariesLigandsAnimals

Author keywords

drug conjugatesintegrinspeptidespeptidomimeticstumor targeting

Substances

PeptidesAntineoplastic AgentsIntegrinsImmunoconjugatesSmall Molecule LibrariesLigands

Authors and institutions

  • Organic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, Bielefeld, Germany.

ORCID profiles: Norbert Sewald

Cite

APA

Paulus, J., & Sewald, N. (2024). Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment. Journal of Peptide Science, 30(7). https://doi.org/10.1002/psc.3561

Vancouver

Paulus J, Sewald N. Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment. Journal of Peptide Science. 2024;30(7). doi:10.1002/psc.3561

BibTeX
@article{Paulus2024,
  author = {Paulus, Jannik and Sewald, Norbert},
  title = {Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment},
  journal = {Journal of Peptide Science},
  year = {2024},
  volume = {30},
  number = {7},
  doi = {10.1002/psc.3561}
}
Start for free →